- Home
- KALA vs CNF Comparison
KALA vs CNF Comparison
Compare KALA & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- CNF
- Stock Information
- Founded
- KALA 2009
- CNF 1999
- Country
- KALA United States
- CNF China
- Employees
- KALA N/A
- CNF N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- KALA Health Care
- CNF Finance
- Exchange
- KALA Nasdaq
- CNF Nasdaq
- Market Cap
- KALA 26.2M
- CNF 30.5M
- IPO Year
- KALA 2017
- CNF 2018
- Fundamental
- Price
- KALA $4.03
- CNF $0.60
- Analyst Decision
- KALA Strong Buy
- CNF
- Analyst Count
- KALA 3
- CNF 0
- Target Price
- KALA $14.00
- CNF N/A
- AVG Volume (30 Days)
- KALA 38.5K
- CNF 305.2K
- Earning Date
- KALA 08-05-2025
- CNF 04-30-2025
- Dividend Yield
- KALA N/A
- CNF N/A
- EPS Growth
- KALA N/A
- CNF N/A
- EPS
- KALA N/A
- CNF 0.08
- Revenue
- KALA N/A
- CNF $85,661,735.00
- Revenue This Year
- KALA N/A
- CNF $252.34
- Revenue Next Year
- KALA N/A
- CNF N/A
- P/E Ratio
- KALA N/A
- CNF $7.95
- Revenue Growth
- KALA N/A
- CNF N/A
- 52 Week Low
- KALA $2.92
- CNF $0.37
- 52 Week High
- KALA $11.20
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- KALA 53.41
- CNF 58.84
- Support Level
- KALA $4.10
- CNF $0.42
- Resistance Level
- KALA $4.41
- CNF $0.54
- Average True Range (ATR)
- KALA 0.39
- CNF 0.06
- MACD
- KALA 0.01
- CNF 0.03
- Stochastic Oscillator
- KALA 52.39
- CNF 80.82
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.